Ian Thomas

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without <i>NPM1</i> Mutations

Sylvie Freeman, Robert K. Hills, Paul Virgo et al. · Journal of Clinical Oncology · 2018 · 200 citations · Full text

Medicine, Hematology, Oncology +17

The Housing Pathways of Young People in the UK

David Clapham, Peter Mackie, Scott Orford et al. · Environment and Planning A Economy and Space · 2014 · 195 citations

Social Sciences, Demography, Household Demography +9

Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial

Philip M. Bath, Polly Scutt, Jason P. Appleton et al. · The Lancet · 2019 · 194 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Unified classification and risk-stratification in Acute Myeloid Leukemia

Yanis Tazi, Juan E. Arango‐Ossa, Yangyu Zhou et al. · Nature Communications · 2022 · 175 citations · Full text

Medicine, Hematology, Oncology +17

A randomized assessment of adding the kinase inhibitor lestaurtinib to first-line chemotherapy for FLT3-mutated AML

Steven Knapper, Nigel H. Russell, Amanda Gilkes et al. · Blood · 2016 · 146 citations · Full text

Medicine, Oncology, Pharmacology +11